Bioniche Life Sciences policy is to separate the roles of company management and corporate governance. The composition of the Board reflects this policy.
The roles of Chairman and CEO are separate, and there is a clear majority of non-management directors.
All Directors have a competence that contributes to the development of operating plans put forward by the company's management.
Non-Management Members
of the Board of Directors
Dr. Stan Alkemade
Dr. Lorne Babiuk
Dr. Michel Bazinet
Margaret Cunningham
Pierre-Yves Desbiens
Dr. James Johnson
The Hon. Lyle Vanclief
Management Members
of the Board of Directors
Graeme McRae,
President & CEO, Bioniche Life Sciences
Director Biographies
Dr. Stan Alkemade
Dr. Stan Alkemade received his veterinary degree from the University of Melbourne, Australia. He returned to Canada in 1971 and ran a mixed veterinary practice in Seaforth, Ontario for ten years. He has lectured in the Animal Health Technology program at the Centralia College of Agricultural Technology. In 1986, he joined Vetrepharm Canada Inc. as Technical Director and was responsible for research and development, product registrations, corporate technical services and facilities design. He is currently the President of BioMedEx, a project management firm for the pharmaceutical industry.
Top
Dr. Lorne Babiuk
Dr. Babiuk is Vice-President (Research) at the University of Alberta. Until June, 2007, he was Director of the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan, having joined that University as Assistant Professor in 1973. In his role as Director of VIDO, Dr. Babiuk was very involved in the development of Bioniche’s E. coli O157:H7 cattle vaccine. He also assisted Bioniche in the establishment of two Natural Science and Engineering Research Canada (NSERC)/ Bioniche Industrial Research Chairs in vaccines to reduce food and water contamination. A Saskatchewan native, Babiuk earned a B.Sc. in Soil Science from the University of Saskatchewan in 1967, an M.Sc. in Soil Science two years later, and a PhD in Microbiology in 1972. As a Professor in the Department of Veterinary Microbiology at the Western College of Veterinary Medicine, Babiuk was awarded a Doctor of Science degree by the University, in recognition of his ground-breaking work in vaccine development. Dr. Babiuk’s numerous honours include being named an Officer of the Order of Canada, Fellow of the Royal Society of Canada, Fellow of the Infectious Disease Society of America, Fellow of the Canadian Academy of Health Sciences, and Member of the European Academy of Sciences. In May of this year, he was awarded an Honorary Doctorate from Colorado State University.
Dr. Michel Bazinet
Dr. Bazinet is Chairman and CEO of Replicor Inc. in Laval, Québec. He earned his Medical Degree at Sherbrooke University and completed his training in Urology at McGill University and did a fellowship in Uro-Oncology at the Memorial Sloan-Kettering Cancer Center in New York. He was Assistant Professor in Urology and Oncology at McGill, as well as Attending Urologist at the Royal Victoria Hospital, Montréal General Hospital, and Jewish General Hospital. While at McGill, Dr. Bazinet served as Director of the Prostate Centre for four years. He founded Mediconsult Inc. in 1999 and served as Medical Director until 2000 when the company was acquired. Dr. Bazinet has been involved with Replicor Inc. since 2000.
Margaret Cunningham
Margaret Cunningham has a Ph.D. in marketing from Texas A&M University and an MBA from the University of Calgary. She is Associate Professor of Marketing at the School of Business, Queen's University. Ms. Cunningham has been a Professor at the School of Business, Queen's University since 1989.
Top
Pierre-Yves Desbiens
Mr. Desbiens is Vice-President Finance and Administration and Chief Financial Officer of Supratek Pharma Inc. He holds a Bachelor’s degree in Accounting from the University of Québec and an MBA from the Hautes Etudes Commerciales of the University of Montréal. Before joining Supratek in March, 2007, Mr. Desbiens held roles as Vice-President, Finance and Administration at Chronogen Inc., and Investment Portfolio Manager, Life Sciences, at the Québec Solidarity Fund QFL, a venture capital institutional investor in the Canadian life sciences sector. Prior to The Fund, Mr. Desbiens was Chief Financial Officer and General Manager of Horizon Sciences & Technologies Inc., a biopharmaceutical company based in Montréal. Before joining the health care sector, Mr. Desbiens held different positions in corporate finance with mid-size to multinational corporations, including Domtar Inc., Price Waterhouse, and Oceanix Inc.
Dr. James Johnson
Dr. James Johnson has a doctorate in biochemistry in addition to his law degree, and is a partner of King & Spalding LLP based in Atlanta, Georgia. He has extensive experience in chemical and biotechnology patent prosecution and licensing.
The Hon. Lyle Vanclief
The Honourable Lyle Vanclief is former Minister of Agricultre and Agri-Food in the Government of Canada who is currently employed as an Agricultural and Agri-Food Consultant. He served as a Member of Parliament for the Government of Canada from 1988 to 2004. Throughout his political career, Mr. Vanclief held several parliamentary appointments, his most recent as Minister of Agriculture and Agri-Food. Prior to serving in public office, Mr. Vanclief previously spent 25 years as an agricultural entrepreneur in his home community of Ameliasburg, Ontario (Prince Edward County). He graduated with a Bachelor of Science degree in Agriculture from the University of Guelph in 1966. Mr. Vanclief is an Independent Director who will have key responsibilities for governance matters.
Top
|
